Fundraising Fox

Seed Health

1 known investors

Microbiome science company selling clinically studied probiotic and supplement formulations under the Seed brand.

Also known as Seed Β· Seed Health, Inc.

Founders & leadership

AKAra Katz
Ara KatzinFounderFounder at Seed Health exited

Investors Β· 1

Company profile

researched Aug 2026

Seed Health is a microbial sciences company that develops applications of bacteria for human and environmental health. Working with academic partners, it translates research into live biotherapeutics and consumer health innovations, with a pipeline described as covering interventions for infectious disease, allergy, and inflammatory conditions across various body sites and windows of development. Its consumer probiotic products are commercialized under the Seed brand.

The consumer line is anchored by DS-01 Daily Synbiotic, a two-in-one capsule product using ViaCap technology in which an outer capsule shields the probiotics from stomach acid and delivers prebiotics while the inner capsule releases 24 live probiotic strains in the colon. The company has expanded beyond the synbiotic into a broader daily supplement range including DM-02 Daily Multivitamin, AM-02 Energy + Focus, and PM-02 Sleep + Restore, along with bundled daily-essentials offerings. Seed also runs a research arm, Seed Labs, focused on non-human/environmental applications of microbial science, and maintains consumer education content under a "Microbiome 101" science section.

Seed Health conducts human clinical research on its formulations, including trials of DS-01 in irritable bowel syndrome, constipation, and post-antibiotic contexts; a Phase II randomized, triple-blind, placebo-controlled trial investigating the gut microbiome in IBS patients has been run at Beth Israel Deaconess Medical Center. In 2019 it organized a community science initiative, #GiveAShit, which assembled a large stool image bank and was recognized in Fast Company's 2020 World Changing Ideas.

Business model

Direct-to-consumer sale of probiotic and supplement products on a monthly subscription basis, with published prices starting at $49.99 per month for DS-01 Daily Synbiotic, $39.99 for DM-02 Daily Multivitamin, and $34.99 each for AM-02 Energy + Focus and PM-02 Sleep + Restore, plus discounted multi-product bundles.

Recurring monthly subscription revenue from consumer supplement formulations sold under the Seed brand.

Traction

The company's website cites over one million health transformations from its products. Its 2019 #GiveAShit community science initiative assembled what was described as the largest bank of stool imagery to date and won Fast Company's 2020 World Changing Ideas award.

Latest developments

Recent company announcements include new data indicating its Co-Biotic formulations modulate the gut microbiome, increasing bioactive vitamin B3, gut-brain metabolites, and sleep-related tryptophan, and the appointment of Anisha Raghavan as the company's first chief marketing officer.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history

Market position

Positions itself as a microbiome science company combining consumer probiotic products with clinical research and academic collaborations rather than as a conventional supplement brand.

Emphasis on clinically studied ingredients, a capsule technology designed for survival through digestion, in-house and partnered clinical trials, and ownership of AI-based digestive health measurement technology acquired from Auggi.

Technology

Seed's DS-01 uses a ViaCap nested-capsule delivery system: an outer capsule protects probiotics from stomach acid and carries prebiotics, while an inner capsule delivers 24 live probiotic strains to the colon. Through its acquisition of Auggi, the company added deep learning technology for automated stool image detection and consistency characterization, using computer vision and deep convolutional neural networks trained against the Bristol Stool Chart benchmark, reported at 94.07% accuracy in predicting the correct Bristol class within one level versus about 75% for self-assessment, along with a mobile monitoring application used in clinical research.

Go-to-market

Online direct-to-consumer sales via the company's website, supported by a product recommendation quiz, subscription pricing, customer testimonials, and science-education content; credibility is also built through academic collaborations and clinical trials.

Consumers seeking gut, digestive, energy, sleep, and general nutritional support; clinical research participants and investigators are engaged through the company's trial programs.

Geography

Announcements are issued from Los Angeles; clinical research collaborations referenced include Massachusetts General Hospital and Beth Israel Deaconess Medical Center in the United States.

History

Seed Health was co-founded by Ara Katz, who serves as co-CEO. In 2019 the company ran the #GiveAShit community science initiative to build a stool image database, and in February 2021 it acquired the technology assets of digital health company Auggi, subsequently integrating Auggi's mobile tracking application into its clinical trials and planning a consumer-facing digital product built on the AI and stool database for 2021.

Compiled by commissioned research from 2 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Auggi stool characterization accuracy (within one Bristol level)Feb 202194.1%
DM-02 Daily Multivitamin subscription priceJan 2026$39.99
DS-01 Daily Synbiotic subscription priceJan 2026$49.99
Live probiotic strains in DS-01Jan 202624 strains
Reported health transformationsJan 2026Over 1 million

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Timeline Β· 4

launches, deals, and filings
Jan 2025
Anisha Raghavan appointed first chief marketing officer

Seed Health announced the appointment of Anisha Raghavan as its first-ever chief marketing officer.

source β†—

Jan 2025
New data on Co-Biotic formulations and the microbiome

Seed Health presented data indicating its Co-Biotic formulations modulate the gut microbiome, increasing bioactive vitamin B3, gut-brain metabolites, and sleep-related tryptophan.

source β†—

Feb 2021
Seed Health acquires digital health company Auggi

Seed Health announced the acquisition of Auggi's technology assets, including an AI algorithm for real-time Bristol stool typing, a large stool image database, and a mobile monitoring application for clinical research. Auggi was founded by David Hachuel and Alfonso Martinez.

source β†—

Jan 2020
#GiveAShit community science initiative wins Fast Company 2020 World Changing Ideas

Seed's 2019 #GiveAShit community science initiative, which amassed the stool imagery bank used to train Auggi's algorithms, was named a winner of Fast Company's 2020 World Changing Ideas.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

β–ΈResearch sources Β· 2

primary sources listed

2 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Seed Health do?
Microbiome science company selling clinically studied probiotic and supplement formulations under the Seed brand.
Who founded Seed Health?
Seed Health was founded by Ara Katz.
Who are Seed Health's investors?
Seed Health's investors include The Chernin Group (TCG Crypto).